Day: December 11, 2025

TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that Shelley Potts will be stepping down from the Company’s Board of Directors (the “Board”), effective December 31, 2025. The Company also announced that Michael Bumby will be rejoining the Board, effective January 1, 2026, bringing extensive experience in finance and governance to support MediPharm’s strategic priorities. Michael Bumby previously served on the Board and was Chief Financial Officer at VIVO Cannabis Inc., which MediPharm acquired in 2023. In addition to his experience in the cannabis sector, Michael has held senior leadership roles in global pharmaceutical companies, providing strategic and financial...

Newport Beach, CA, Dec. 10, 2025 (GLOBE NEWSWIRE) — Bimergen Energy Corporation (OTCQB: BESS) (“Bimergen”), a utility-scale battery energy storage systems (BESS) asset owner, project developer, and independent power provider, today announced that its shares of common stock have been approved for listing on the NYSE American LLC (“NYSE American”) stock exchange. Bimergen expects that its common stock will begin trading on the NYSE American under the symbol “BESS” at the opening of trading on or about December 18, 2025, subject to authorization of the application and continued compliance with the exchange rules. In connection with the anticipated uplisting, Bimergen is also conducting a concurrent offering of its securities, subject to market conditions and regulatory approval. Additional details regarding the offering...